Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 28, Issue 2, 2010, Pages 223-229

  Wells, Daniel K ^a   Ward, Michael M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Cardiovascular disease; Lupus nephritis; Myocardial infarction; Systemic lupus erythematosus

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOLYTIC ANEMIA; HUMAN; LUNG DISEASE; LUNG EMBOLISM; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PLEURISY; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ADULT; AGED; ANEMIA, HEMOLYTIC; CALIFORNIA; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; EPILEPSY; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLEURISY; RISK FACTORS; THROMBOCYTOPENIA;

EID: 77952757974     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. AVALOS I, RHO YH, CHUNG CP, STEIN CM: Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2008; 26 (Suppl. 51): S5-S13.
2. JONSSON H, NIVED O, STURFELT G: Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989; 68: 141-150 (Pubitemid 19132411)
3. MANZI S, MEILAHN EN, RAIRIE JE et al.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-415
4. WARD MM: Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-346
5. ESDAILE JM, ABRAHAMOWICZ M, GRODZICKY T et al.: Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331-2337
6. FISCHER LM, SCHLIENGER RG, MATTER C, JICK H, MEIER CR: Effect of rheuamtoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004; 93: 198-200. (Pubitemid 38058729)
7. BJÖRNÅDAL L, YIN L, GRANATH F, KLARESKOG L, EKBOM A: Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-1995. J Rheumatol 2004; 31: 713-719
8. PETRI M, PEREZ-GUTTHANN S, SPENCE D, HOCHBERG MC: Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519
9. BESSANT R, HINGORANI A, PATEL L, MACGREGOR A, ISENBERG DA, RAHMAN A: Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology 2004; 43: 924-929
10. RAHMAN P, UROWTIZ MB, GLADMAN DD, BRUCE IN, GENEST J JR: Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol 1999; 26: 2363-2368 (Pubitemid 29528973)
11. MANGER K, MANGER B, REPP R et al.: Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002; 61: 1065-1070
12. TOLOZA SMA, URIBE AG, MCGWIN G JR et al.: Systemic lupus erythematosus in a multiethnic U.S. Cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947-3957
13. BESSANT R, DUNCAN R, AMBLER G et al.: Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum 2006; 55: 892-899 (Pubitemid 44917462)
14. UROWITZ MB, IBAÑEZ, GLADMAN DD: Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007; 34: 70-75
15. SVENUNGSSON E, JENSEN-URSTAD K, HEIMBÜRGER M et al.: Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893 (Pubitemid 32983229)
16. BERTOLI AM, VILA LM, ALARCÓN GS et al.: Factors associated with arterial vascular events in PROFILE: a multiethnic lupus cohort. Lupus 2009; 18: 958-965
17. WHISNANT JP: Modeling of risk factors for ischemic stroke: the Willis lecture. Stroke 1997; 28: 1840-1844 (Pubitemid 27391458)
18. YUSUF S, HAWKENS S, OUNPUU S et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952 (Pubitemid 39208455)
19. THOMPSON SG, GREENBERG G, MEADE TW: Risk factors for stroke and myocardial infarction in women in the United Kingdom as assessed in general practice: a case-control study. Br Heart J 1989; 61: 403-409 (Pubitemid 19129129)
20. OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT: Editing Criteria Handbook. Sacramento, CA: Office of Statewide Health Planning and Development, 1995.
21. OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT: Report of results from the OSHPD reabstracting project: an evaluation of the reliability of selected patient discharge data, July through December 1988. Sacramento, CA: Office of Statewide Health Planning and Development, 1990.
22. OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT: Second report of the California Hospital Outcomes Project: acute myocardial infarction. Vol 2 (technical appendix). Sacramento, CA: Office of Statewide Health Planning and Development, 1996.
23. ROMANO PS, MARK DH: Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care 1994; 32: 81-90.
24. OFFICE OF STATEWIDE HEALTH PLANNING AND DEVELOPMENT: Heart Attack Outcomes 1994 - 1996. vol 2 (technical guide). Sacramento, CA: Office of Statewide Health Planning and Development, 2002.
25. SARNAK MJ, LEVEY AS: Epidemiology of cardiac disease in dialysis patients. Semin Dial 1999; 12: 69-76.
26. U.S. RENAL DATA SYSTEM: USRDS 2000 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000.
27. SØRENSEN HT, HORVATH-PUHO E, PEDERSEN L, BARON JA, PRANDONI P: Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370: 1773-1779
28. PETRI M: The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort. Thromb Res 2004; 114: 593-595
29. LINNEMANN B, SCHINDEWOLF M, ZGOURAS D, ERBE M, JAROSCH-PREUSCHE M, LINDHOFF-LAST E: Are patients with thrombophilia and previous venous thromboembolilsm at higher risk to arterial thrombosis? Thromb Res 2008; 121: 743-750
30. URBANUS RT, SIEGERINK B, ROEST M, ROSENDAAL RF, DE GROOT PG, ALGRA A: Antiphospholipid antibodies and risk of myocardial infarction and ischemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
31. TARR T, LAKOS G, BHATTOA HP, SZEGEDI G, SHOENFELD Y, KISS E: Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Lupus 2007; 16: 324-328 (Pubitemid 47074833)
32. BREIMAN L, FRIEDMAN J, STONE CJ, OLSHEN RA: Classification and Regression Trees. 1984; Monterey, CA: Wadsworth Inc.
33. ASANUMA Y, OESER A, SHITANI AK et al.: Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-2415 (Pubitemid 37542989)
34. SELTZER F, SUTTON-TYRRELL K, FITZGERALD SG et al.: Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004; 50: 151-159
35. WOLAK T, TODOSOUI E, SZENDRO G et al.: Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study. J Rheumatol 2004; 31: 909-914
36. MAKSIMOWICZ-MCKINNON K, MAGDER LS, PETRI M: Predictors of carotid atherosclerosis in systemic lupus erythematosus. J Rheumatol 2006; 33: 2458-2463 (Pubitemid 46067826)
37. MANZI S, SELZER F, SUTTON-TYRRELL K et al.: Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51-60. (Pubitemid 29042570)
38. ROMAN MJ, SHANKER B-A, DAVIS A et al.: Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406 (Pubitemid 37542988)
39. JIMÉNEZ S, GARCÍA-CRIADO MA, TÀSSIES D et al.: Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology 2005; 44: 756-761 (Pubitemid 41487204)
40. VON FELDT JM, SCALZI LV, CUCCHIARA AJ et al.: Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2220-2227
41. AHMAD Y, SHELMERDINE J, BODILL H et al.: Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology 2007; 46: 983-988
42. MANGER K, KUSUS M, FORSTER C et al.: Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003; 62: 846-850
43. DORIA A, SHOENFELD Y, WU R et al.: Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 1071-1077 (Pubitemid 37323571)
44. RIDKER PM: Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007; 65: S253-9.
45. WESTERWEEL PE, LUYTEN RKMAC, KOOMANS HA, DERKSEN RHWM, VERHAAR MC: Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1384-1396 (Pubitemid 46764065)
46. ORDOÑEZ JD, HIATT RA, KILLEBREW EJ, FIREMAN BH: The increased risk of coronary artery disease associated with nephrotic syndrome. Kidney Int 1993; 44: 638-642 (Pubitemid 23265235)
47. DIANGELANTONIO E, DANESH J, EIRIKSDOTTIR G, GUDNASON V: Renal function and risk of new coronary heart disease in general populations: new prospective study and systematic review. PLoS Med 2007; 4: e270.
48. HERBST AL, ULFELDER H, POSKANZER DC: Adenocarcinoma of the vagina. Association of maternal stilbesterol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-881
49. WAGNER JC, SLEGGS CA, MARCHAND P: Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape province. Br J Ind Med 1960; 17: 260-271